Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1998
06/03/1998EP0845530A2 Interferon gamma inducing factor
06/03/1998EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library
06/03/1998EP0845476A2 Synthetic catalytic oligonucleotides
06/03/1998EP0845271A1 Dressing material having a calcium alginate matrix and method of making the same
06/03/1998EP0845265A1 Mucosal preparation containing physiologically active peptide
06/03/1998EP0845045A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845035A2 Urocortin peptides
06/03/1998EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/03/1998EP0845006A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
06/03/1998EP0845002A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
06/03/1998EP0844996A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
06/03/1998EP0844887A1 Aav transduction of myoblasts
06/03/1998EP0844877A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol
06/03/1998EP0844875A2 Use of basic amino acids and derivatives for lowering ceramide levels
06/03/1998EP0844873A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
06/03/1998EP0683767B1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
06/03/1998EP0509984B1 Method of preparing lysozyme dimers
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183785A Novel peptides and remedy for bone diseases contg. same as active ingredient
06/03/1998CN1183781A Novel heterocyclic compounds
06/03/1998CN1183769A Alpha -(substd. alkylphenyl) -4 -(hydroxy -diphenylmethyl) -1 -piperidine butanol derivs., their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
06/03/1998CN1183765A Phenoxyethyamine derivs. having high affinity for 5 -HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical composition contg. said derivs
06/03/1998CN1183726A Synthetic cryptophycins
06/03/1998CN1183720A Method for treatment of macular degeneration
06/03/1998CN1183717A Use of R-NSAID in protective composition for treatment of colorectal cancer
06/03/1998CN1038585C Process for preparation of 2, 4 - and 2, 5 -substd. pyridine -N -oxides
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760214 Bone resorption inhibition/osteogenesis promotion compound
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760087 Glycylanilide derivatives, their preparation and their application in therapy
06/02/1998US5760084 Treating dermatological disorders
06/02/1998US5760082 Dietetic foods containing conjugated linoleic acids
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760072 Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
06/02/1998US5760061 Using a benzothiophene compound
06/02/1998US5760059 Indole derivatives
06/02/1998US5760057 Anticoagulants
06/02/1998US5760054 Alpha IC adrenergic receptor antagonists
06/02/1998US5760047 Method for treatment of obesity using prolactin modulators and diet
06/02/1998US5760041 4-aminoquinazoline EGFR Inhibitors
06/02/1998US5760037 Derivatives of N'N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene diamine and the use thereof in pharmaceutical and cosmetic compostions
06/02/1998US5760027 Use of 7-alkylidene cephalosporins to inhibit elastase activity
06/02/1998US5760024 Using cyclooxygenase inhibitors such as aspirin to promote embryo implantation
06/02/1998US5760022 Pharmaceutical composition with improved bioavailability of inositol phosphate
06/02/1998US5760019 Inhibit protease enzymes
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5759996 Reduce bone resorption, angiogenesis, and restenosis
06/02/1998US5759994 Antithrombin peptide for cardiovascular disorders
06/02/1998US5759808 Immunoglobulins devoid of light chains
06/02/1998US5759804 Culture product
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759567 Administering to poultry l-dihydroxyphenylalanine to reduce the ratio of saturated to unsaturated fatty acids in eggs
06/02/1998US5759548 Using plant extract
06/02/1998US5759543 Application of a cell culture of a fusarium fungus strain producer for medical uses
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
06/02/1998CA2012278C Mutant of microbacterium, a strain 851r, and a process for producing 851r nutrient solution by application of the strain
06/02/1998CA1339895C Piperidinoalkyl derivatives of carboxylic acid amides
05/1998
05/28/1998WO1998022619A1 Metal mediated serine protease inhibitors
05/28/1998WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022493A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022487A1 Combinatorial synthesis of carbohydrate libraries
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022459A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
05/28/1998WO1998022458A1 Multivalent salts of pyridostigmine and related compounds
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022132A1 A method and composition for enabling passage through the blood-brain barrier
05/28/1998WO1998022130A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
05/28/1998WO1998022128A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/28/1998WO1998022127A1 Pretreatment with growth factors to protect against cns damage
05/28/1998WO1998022109A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998WO1998022108A1 Triaryl substituted imidazoles and methods of use
05/28/1998WO1998022106A1 Pharmaceutical composition
05/28/1998WO1998022100A2 New use for 1,3-propanediol derivatives
05/28/1998WO1998022090A1 Treatment of equine laminitis
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998021956A1 Heregulin antagonists and methods for their use
05/28/1998WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998WO1998012328A3 Human bad polypeptides, encoding nucleic acids and methods of use
05/28/1998DE19648793A1 Neue Benzamide und deren Anwendung New benzamides and their application
05/28/1998CA2273183A1 Treatment of equine laminitis
05/28/1998CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998CA2272280A1 A method and composition for enabling passage through the blood-brain barrier
05/28/1998CA2272073A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
05/28/1998CA2272050A1 Secreted proteins and polynucleotides encoding them
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271941A1 Triaryl substituted imidazoles and methods of use
05/28/1998CA2271893A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998CA2271786A1 Multivalent salts of pyridostigmine and related compounds
05/28/1998CA2271783A1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998CA2270876A1 N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
05/28/1998CA2270407A1 Human kdel receptor
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
1 ... 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 ... 1564